In a double-blind, prospective, randomised trial in 51 female patients, atracurium 0.6mglkg provided acceptable intubating conditions more rapidly than did alcuronium 0.25mglkg. Atracurium produced more profound neuromuscular twitch suppression than alcuronium. The effect of atracurium was longer-lasting than that of alcuronium (32 minutes and 22 minutes respectively to achieve 10% recovery) and it took slightly longer to reverse with neostigmine. Seven patients in the atracurium group who underwent short surgical procedures required supplementary neostigmine to achieve adequate reversal. Two cases of sinus bradycardia were noted in the atracurium group, but hypotension was not a clinical problem in any patient. Atracurium appears to be a useful relaxant, but a smaller dose than that used here should be chosen for short procedures.
sterilisation or tubal ligation by the 'minilaparotomy' technique were studied. Any patient suffering from neuromuscular disease, asthma, renal disease, hepatic disease or having a history of hypersensitivity to muscle relaxants was excluded. Written, informed consent was obtained from each patient, and the study was approved by the hospital ethical committee.
Anaesthetic management
Each patient received premedication with omnopon 0.25mg/kg and hyoscine 0.005mg/kg IM one hour prior to surgery. Anaesthesia was induced with thiopentone given intravenously in the left arm at a rate of 250mg/15 seconds until the eyelash reflex was lost.
Anaesthesia was then maintained by the spontaneous inhalation of nitrous oxide, oxygen and halothane 0.5070 until a control train-of-four recording had been obtained. Each patient then received, on a random basis, either atracurium 0.6mg/kg (26 cases) or alcuronium 0.25mg/kg (25 cases). These doses were recommended by the manufacturers as suitable for facilitating intubation (Wellcome, NZ Ltd, private communication, and Roche Ltd alcuronium prescribing information). Each relaxant dose was diluted to S ml with normal saline, and the anaesthetist did not know which drug was being given. Respiration was controlled manually as paralysis developed. Laryngoscopy was performed at intervals of one minute from the time of relaxant administration. At each laryngoscopy intubating conditions were scored according to a modification of the scheme of Lund and Starner. 6 The criteria used for scoring are as follows: 0 -Mouth-opening poor. Laryngoscopy impossible. 1 -Cords visualised but moving.
-Cords visualised and still. Patient coughs
or bucks at intubation. 3 -Cords visualised and still. Patient does not cough or buck at intubation. Once a score of 2 or more was achieved intubation was performed using a size 8.0mm Magill cuffed endotracheal tube.
Anaesthesia was maintained by controlled ventilation with nitrous oxide 70%, oxygen and halothane O.SOJo given via a circle system with the C02 absorber turned off. Fresh gas flows were adjusted to 80mls/kg/minute to ensure approximate normocarbia. Inspired oxygen was measured with a fuel cell analyser.
Blood pressure and pulse rate were recorded using an Arteriosonde (R) and a digital pulse monitor before induction, before intubation, after intubation, and at S-minute intervals thereafter for the duration of the procedure.
Once surgery was complete, neostigmine 2.Smg and atropine I.2mg were administered. When the anaesthetist judged on clinical grounds that adequate spontaneous respiration had returned, the patient was extubated. The anaesthetist scored the condition of the patient at the time of extubation using the following criteria: 1 -Just adequate muscle power. 2 -Adequate but not full muscle power. 3 -Full muscle power present.
The patients were then transferred to the recovery room where they were observed closely. Blood pressure, pulse rate, and the ability of the patient to maintain a head lift for S seconds were recorded at lO-minute intervals. The time at which the recovery staff considered that the patient was ready for return to the ward was also noted.
Neuromuscular monitoring
Neuromuscular monitoring was accomplished by the application of a supramaximal train-of-four stimulation to the ulnar or median nerve at the wrist. The force of movement of the thumb was recorded by means of strain gauges adherent to a flexible metal strip to which the thumb was attached, according to the method described by Fiore and his co-workers. 7 The thumb movements quantified by the strain gauges were displayed and recorded on an EMI SE 3006 U-V chart recorder. The monitoring equipment was positioned in such a way that the anaesthetist could not see the results. He based his actions, therefore, solely on clinical grounds.
Following induction of anaesthesia a control recording was obtained. After administration of the relaxant, recordings were made at IS-second intervals for a period of 4 minutes and then every 2 minutes until atropine/ neostigmine was administered. Recordings were then made every IS seconds until extubation was performed. Scrutiny of the twitch heights obtained allowed the computation of the ratio of first twitch height to the control twitch height (Tl/Tc) and the ratio of fourth twitch height to first twitch height (T4/Tl).
Surgical technique
The numbers of patients who underwent laparoscopic sterilisation and 'minilaparotomy' tubal ligation in each relaxant group are shown in Table 1 . Carbon dioxide was used to inflate the abdomen during laparoscopy. The surgeon's assessment of abdominal wall relaxation was recorded as 'excellent', 'satisfactory' or 'unsatisfactory' in each case. 
RESULTS
There were no significant differences between the two groups with respect to age, weight or ASA status (Table 1 ). The times for operations were also comparable, mean durations being 26 (S.D.8) minutes for the atracurium group, and 22 (S.D.6) minutes for the alcuronium group. (i) Intubation. Table 2 shows the cumulated number of patients that had been intubated by 1, 2 and 3 minutes. At 1 minute there were more patients in the atracurium group intubated than in the alcuronium group. At 2 minutes the difference was statistically significant (p = 0.025). No patient required extra relaxant to facilitate intubation, and all cases exhibited satisfactory intubating conditions by 3 minutes.
(ii) Cardiovascular recordings. Four patients in the atracurium group and two patients in the alcuronium group exhibited an intra-operative fall in blood pressure of more than 15070 of the pre-operative systolic level. No patient exhibited a fall of more than 30% of pre-operative systolic level. Two of the four patients referred to above in the atracurium group exhibited hypotension associated with sinus bradycardia (48 and 52
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One patient from each group showed brief periods of ventricular ectopic coupled beats. There was no haemodynamic disturbance, and spontaneous reversion to sinus rhythm occurred within a few minutes in both cases.
(iii) Extubation. The extubation scores in both groups were virtually identical, indicating that a uniform end-point for the clinical decision to extubate the patient was used. The mean time elapsed between administration of reversal and the decision to extubate the patients was 284 seconds (S.D. 130 seconds) for atracurium, and 223 seconds (S.D. 112 seconds) for alcuronium (p>0.05). The survival curves for the number of patients extubated against time elapsed from the point of atropine/neostigmine administration are shown in figure 1. It can be seen that the patients in the alcuronium group tended to be extubated earlier than those in the atracurium group. Seven patients in the atracurium group were given further doses of reversal on clinical grounds. None of the alcuronium group required supplementary reversal. This difference is significant (p<O.OOI). Of these seven patients, six received the extra neostigmine while still intubated in theatre as a result of delay in the return of satisfactory respirations, while one received extra neostigmine in recovery. In all of these seven patients muscular strength rapidly returned within a short period of time. All seven had undergone short surgical procedures in the range of 13-26 minutes and none of them showed any spontaneous recovery of thumb twitch at the time of reversal. In the atracurium group, six other patients had surgical procedures which lasted under 26 minutes (range 14-25) and these showed adequate reversal of relaxation with the first dose of neostigmine.
(iv) Recovery. No patient exhibited hypotension of more than 15070 of pre-operative systolic value or clinically detectable arrhythmias while in the recovery room. In no case was muscle weakness the cause of delay in return to the wards from the recovery room. The mean time elapsed before return of the patients to the wards was comparable in the two groups, for the atracurium group 27 minutes and for alcuronium group 28 minutes.
(v) Surgical relaxation. In all patients except one, muscle relaxation of the abdominal wall was rated as adequate or excellent by the surgeon. The one exception was in the alcuronium group. This patient exhibited only a 40070 depression of twitch height, but was easily intubated one minute after relaxant administration.
Neuromuscular monitoring
(i) Onset of blockade. The mean time taken for the first perceptible depression of muscle twitch to occur was 48 (S.D. 16) seconds for the atracurium group, and 60 (S.D.22) seconds for the alcuronium group. There was no statistical difference between the groups in this respect. A depression of 90070 in the height of the first twitch was achieved by all cases in the atracurium group, but by only 20 out of 25 cases in the alcuronium group. The median times for 90070 depression to be achieved were: atracurium group 135 seconds, alcuronium group 360 seconds. This difference is highly significant (p<O.OOOI). Complete disappearance of muscular twitch was achieved in all cases in the atracurium group, but in only 13 out of 25 cases in the alcuronium group. The median times for complete disappearance to occur were 3 minutes for the atracurium group, 14 minutes for the a1curonium group (p<O.OOOI).
(ii) Spontaneous recovery. As the length of surgical procedure varied between 13 and 40 minutes in different cases conclusions regarding the time taken to achieve spontaneous recovery of muscle twitch are difficult. We have been able to compute the time taken for recovery of 10070 of the control twitch height to occur from the time of maximum twitch depression in each case. The median times for this 10070 recovery to occur were as follows -atracurium group 32 minutes, alcuronium group 22 minutes (p<0.02).
DISCUSSION
The dosages of relaxants used in this study were those recommended by the manufacturers as efficient intubating doses. In fact, 0.6mg/kg of atracurium represents approximately three times the ED95 dose for this drug, whereas 0.25mg/kg represents a little over one ED95 dose for alcuronium. Thus, in pharmacological terms, equipotent doses of the relaxants were not compared. However, this was an investigation of clinically recommended doses. The discrepancy in the pharmacological sizes of the doses used means that differences in behaviour of these two relaxants cannot be ascribed to any intrinsic differences in their properties.
With 0.6mg/kg of atracurium, good intubating conditions are rapidly achieved. Atracurium would seem to be a suitable drug for use if succinylcholine is contraindicated. However, the onset of action was not as rapid in either group as the onset generally experienced when using succinylcholine. 8 The rapid onset of good intubating conditions in the atracurium group was paralleled by the rapid onset of neuromuscular blockade as measured by nerve stimulation at the wrist. This was not so in the alcuronium group. Factors such as depth of anaesthesia, as well as neuromuscular blockade, influence the ease of intubation. The difficulty of standardising anaesthetic depth and of ascribing intubating conditions to neuromuscular blockade was well illustrated by the patient who was rated as poorly relaxed by the surgeon, and who only achieved 40070 depression of first twitch height, but was intubated with a score of 2 at one minute after relaxan t administration.
Spontaneous recovery of neuromuscular twitch was achieved more rapidly in the a1curonium group than in the atracurium Anaesthesia and Intensive Care, Vol. /3, No. /, February, 1985 group. This is consistent with the relatively larger dose of atracurium used. Robertson et al. 9 reported that in their comparison of atracurium with vecuronium (ORG NC 45), the time for recovery from 75'"10 to 25'"10 twitch depression of vecuronium rose as the dose increased, whereas the recovery rate of atracurium remained constant. It was suggested by these workers that redistribution may play a significant role in the termination of action of vecuronium. [f alcuronium behaves in a similar way to vecuronium then the relatively shorter duration of action exhibited in this study may not be so noticeable if larger, or repeated, doses of relaxants are used.
One feature of this study noted by those taking part was the poor correlation between clinical judgement of acceptable reversal of neuromuscular blockade and the quantitative evidence of reversal obtained from ulnar nerve stimulation. [n several instances respiratory function was judged to be clinically acceptable (and indeed proved to be so) when only minimal return of neuromuscular function was evident from the train-of-four recordings. The diaphragmatic sparing phenomenon is well recognised with nondepolarising relaxants and this may well be far more important than generally realised when making a clinical decision to extubate.
No serious cardiovascular disturbance occurred in any patient. The two cases of sinus bradycardia cannot necessarily be ascribed to atracurium as halothane was in use at the time. Reports have recently appeared, however, referring to the occurrence of bradycardia during atracurium use. 10.11 There was no clinical evidence of histamine release in any patient in this study.
We conclude that atracurium O.6mg/kg is associated with the rapid onset of good intubating conditions, and with cardiovascular stability. In view of the delay in achievement of adequate reversal after particularly short Anaesthesia and If/lensive Care, Vol. 13, No. I, February, 1985 surgical procedures, we suggest that a smaller dose of atracurium than that used in this study be employed in these circumstances.
